About Delfa

Billions of people still suffer from everyday diseases.

One key reason? Clinical trials are broken.

Despite $120 billion spent each year, most trials are delayed due to bottlenecks like patient recruitment.

Delfa is fixing this with autonomous AI agents. We're building AI agents to automate clinical trials.

In less than a year from launch we’ve already:

• Deployed onto 300+ trials across multiple conditions

• Reached seven figures in ARR, growing 25% MoM

• Raised an oversubscribed $3.8m seed from tier‑one AI investors

Overview

Delfa is at a critical inflection: we have a proven offering which is on track to support the recruitment of thousands of participants into trials in 2026, while simultaneously expanding our offerings with new products for biopharmaceutical companies.

You’ll work directly with our...